These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

229 related articles for article (PubMed ID: 33990606)

  • 1. Characterization of an engineered live bacterial therapeutic for the treatment of phenylketonuria in a human gut-on-a-chip.
    Nelson MT; Charbonneau MR; Coia HG; Castillo MJ; Holt C; Greenwood ES; Robinson PJ; Merrill EA; Lubkowicz D; Mauzy CA
    Nat Commun; 2021 May; 12(1):2805. PubMed ID: 33990606
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Improvement of a synthetic live bacterial therapeutic for phenylketonuria with biosensor-enabled enzyme engineering.
    Adolfsen KJ; Callihan I; Monahan CE; Greisen PJ; Spoonamore J; Momin M; Fitch LE; Castillo MJ; Weng L; Renaud L; Weile CJ; Konieczka JH; Mirabella T; Abin-Fuentes A; Lawrence AG; Isabella VM
    Nat Commun; 2021 Oct; 12(1):6215. PubMed ID: 34711827
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of Human Performance Aiding Live Synthetically Engineered Bacteria in a Gut-on-a-Chip.
    Nelson MT; Coia HG; Holt C; Greenwood ES; Narayanan L; Robinson PJ; Merrill EA; Litteral V; Goodson MS; Saldanha RJ; Grogg MW; Mauzy CA
    ACS Biomater Sci Eng; 2023 Sep; 9(9):5136-5150. PubMed ID: 36198112
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development of a synthetic live bacterial therapeutic for the human metabolic disease phenylketonuria.
    Isabella VM; Ha BN; Castillo MJ; Lubkowicz DJ; Rowe SE; Millet YA; Anderson CL; Li N; Fisher AB; West KA; Reeder PJ; Momin MM; Bergeron CG; Guilmain SE; Miller PF; Kurtz CB; Falb D
    Nat Biotechnol; 2018 Oct; 36(9):857-864. PubMed ID: 30102294
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genetically modified bacteria enlisted in fight against disease.
    Reardon S
    Nature; 2018 Jun; 558(7711):497-498. PubMed ID: 29946090
    [No Abstract]   [Full Text] [Related]  

  • 6. Development of a mechanistic model to predict synthetic biotic activity in healthy volunteers and patients with phenylketonuria.
    Charbonneau MR; Denney WS; Horvath NG; Cantarella P; Castillo MJ; Puurunen MK; Brennan AM
    Commun Biol; 2021 Jul; 4(1):898. PubMed ID: 34294862
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pathomimetic modeling of human intestinal diseases and underlying host-gut microbiome interactions in a gut-on-a-chip.
    Shin W; Kim HJ
    Methods Cell Biol; 2018; 146():135-148. PubMed ID: 30037458
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Safety and pharmacodynamics of an engineered E. coli Nissle for the treatment of phenylketonuria: a first-in-human phase 1/2a study.
    Puurunen MK; Vockley J; Searle SL; Sacharow SJ; Phillips JA; Denney WS; Goodlett BD; Wagner DA; Blankstein L; Castillo MJ; Charbonneau MR; Isabella VM; Sethuraman VV; Riese RJ; Kurtz CB; Brennan AM
    Nat Metab; 2021 Aug; 3(8):1125-1132. PubMed ID: 34294923
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Engineered bacteria can function in the mammalian gut long-term as live diagnostics of inflammation.
    Riglar DT; Giessen TW; Baym M; Kerns SJ; Niederhuber MJ; Bronson RT; Kotula JW; Gerber GK; Way JC; Silver PA
    Nat Biotechnol; 2017 Jul; 35(7):653-658. PubMed ID: 28553941
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Technological tools and strategies for culturing human gut microbiota in engineered in vitro models.
    Sardelli L; Perottoni S; Tunesi M; Boeri L; Fusco F; Petrini P; Albani D; Giordano C
    Biotechnol Bioeng; 2021 Aug; 118(8):2886-2905. PubMed ID: 33990954
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Redesign of an Escherichia coli Nissle treatment for phenylketonuria using insulated genomic landing pads and genetic circuits to reduce burden.
    Triassi AJ; Fields BD; Monahan CE; Means JM; Park Y; Doosthosseini H; Padmakumar JP; Isabella VM; Voigt CA
    Cell Syst; 2023 Jun; 14(6):512-524.e12. PubMed ID: 37348465
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Engineering Diagnostic and Therapeutic Gut Bacteria.
    Landry BP; Tabor JJ
    Microbiol Spectr; 2017 Oct; 5(5):. PubMed ID: 29052539
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fitting tissue chips and microphysiological systems into the grand scheme of medicine, biology, pharmacology, and toxicology.
    Watson DE; Hunziker R; Wikswo JP
    Exp Biol Med (Maywood); 2017 Oct; 242(16):1559-1572. PubMed ID: 29065799
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Engineered bacteria titrate hydrogen sulfide and induce concentration-dependent effects on the host in a gut microphysiological system.
    Hayes JA; Lunger AW; Sharma AS; Fernez MT; Carrier RL; Koppes AN; Koppes R; Woolston BM
    Cell Rep; 2023 Dec; 42(12):113481. PubMed ID: 37980564
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthetic Biology and Engineered Live Biotherapeutics: Toward Increasing System Complexity.
    Ozdemir T; Fedorec AJH; Danino T; Barnes CP
    Cell Syst; 2018 Jul; 7(1):5-16. PubMed ID: 30048620
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gut-liver on a chip toward an in vitro model of hepatic steatosis.
    Lee SY; Sung JH
    Biotechnol Bioeng; 2018 Nov; 115(11):2817-2827. PubMed ID: 29981260
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gut-on-a-chip: Current progress and future opportunities.
    Ashammakhi N; Nasiri R; Barros NR; Tebon P; Thakor J; Goudie M; Shamloo A; Martin MG; Khademhosseini A
    Biomaterials; 2020 Oct; 255():120196. PubMed ID: 32623181
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bacterial variability in the mammalian gut captured by a single-cell synthetic oscillator.
    Riglar DT; Richmond DL; Potvin-Trottier L; Verdegaal AA; Naydich AD; Bakshi S; Leoncini E; Lyon LG; Paulsson J; Silver PA
    Nat Commun; 2019 Oct; 10(1):4665. PubMed ID: 31604953
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A body-on-a-chip (BOC) system for studying gut-liver interaction.
    Sung JH
    Methods Cell Biol; 2020; 158():1-10. PubMed ID: 32423644
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Can the Microbiome Deliver? A Proof-of-Concept Engineered E. coli PKU Therapeutic.
    Alteri CJ
    Cell Host Microbe; 2019 Apr; 25(4):473-474. PubMed ID: 30974078
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.